Indicaton

Cancer Immunotherapy Enhancer
ApyraMed has shown to promote the effective generation of self-renewing anti-tumor cytotoxic T cells and synergize with ICIs in controlling tumor growth, thus resulting in superior survival in experimental models of solid tumors.

Therapeutic indications
Type of product
Table
  • Phase

    Discovery

  • Partnering status

    Not partnered

  • Available in

    World-Wide